Literature DB >> 1943479

Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment.

T A Kosten1, D W Marby, E J Nestler.   

Abstract

Previous research shows that buprenorphine (BUP), a mixed opioid agonist-antagonist, reduces cocaine use in humans and suppresses cocaine self-administration in monkeys. The present study found that BUP reduces cocaine's ability to condition a place preference in rats. Compared to vehicle treated rats, rats treated with BUP 2 times/day for 2 weeks spent significantly less time in the cocaine conditioned place compared to their respective saline trained controls. No conditioned place preference was shown for BUP alone. These results further implicate a role for the opioid system in cocaine use and stress the importance of differentiating chronic vs. acute opioid effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1943479     DOI: 10.1016/0024-3205(91)90490-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.

Authors:  Taline V Khroyan; Willma E Polgar; Gerta Cami-Kobeci; Stephen M Husbands; Nurulain T Zaveri; Lawrence Toll
Journal:  J Pharmacol Exp Ther       Date:  2010-12-21       Impact factor: 4.030

2.  Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability.

Authors:  Ty A Ridenour; Mildred Maldonado-Molina; Wilson M Compton; Edward L Spitznagel; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2005-04-26       Impact factor: 4.492

3.  Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice.

Authors:  G C Sartor; S K Powell; H J Wiedner; C Wahlestedt; S P Brothers
Journal:  Brain Res       Date:  2015-12-03       Impact factor: 3.252

Review 4.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

5.  Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine.

Authors:  Sunmee Wee; Laura Orio; Senait Ghirmai; John R Cashman; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2009-05-30       Impact factor: 4.530

Review 6.  The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

Authors:  Jeffrey M Witkin; Michael A Statnick; Linda M Rorick-Kehn; John E Pintar; Michael Ansonoff; Yanyun Chen; R Craig Tucker; Roberto Ciccocioppo
Journal:  Pharmacol Ther       Date:  2013-11-01       Impact factor: 12.310

7.  Effects of concurrent saccharin availability and buprenorphine pretreatment on demand for smoked cocaine base in rhesus monkeys.

Authors:  S D Comer; V R Hunt; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

8.  Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine.

Authors:  Anna M W Taylor; Annie Castonguay; Atefeh Ghogha; Pia Vayssiere; Amynah A A Pradhan; Lihua Xue; Sadaf Mehrabani; Juli Wu; Pat Levitt; Mary C Olmstead; Yves De Koninck; Christopher J Evans; Catherine M Cahill
Journal:  Neuropsychopharmacology       Date:  2015-07-23       Impact factor: 7.853

9.  Oxytocin Attenuates Expression, but Not Acquisition, of Sucrose Conditioned Place Preference in Rats.

Authors:  Devon Patel; Megana Sundar; Eva Lorenz; Kah-Chung Leong
Journal:  Front Behav Neurosci       Date:  2020-12-15       Impact factor: 3.558

Review 10.  Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?

Authors:  Mark S Gold; David Baron; Abdalla Bowirrat; Kenneth Blum
Journal:  J Neurol Sci       Date:  2020-09-15       Impact factor: 3.181

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.